Peter Fortune Portrait

Peter Fortune

Conservative - Bromley and Biggin Hill

302 (0.6%) majority - 2024 General Election

First elected: 4th July 2024


2 APPG memberships (as of 12 Feb 2025)
Cricket, London
Peter Fortune has no previous appointments


Division Voting information

During the current Parliament, Peter Fortune has voted in 67 divisions, and 1 time against the majority of their Party.

26 Nov 2024 - Tobacco and Vapes Bill - View Vote Context
Peter Fortune voted Aye - against a party majority and in line with the House
One of 23 Conservative Aye votes vs 35 Conservative No votes
Tally: Ayes - 415 Noes - 47
View All Peter Fortune Division Votes

Debates during the 2024 Parliament

Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.

Sparring Partners
Hamish Falconer (Labour)
Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)
(3 debate interactions)
Louise Haigh (Labour)
(2 debate interactions)
Alex Norris (Labour (Co-op))
Parliamentary Under-Secretary (Housing, Communities and Local Government)
(1 debate interactions)
View All Sparring Partners
Department Debates
HM Treasury
(2 debate contributions)
Department for Work and Pensions
(2 debate contributions)
View All Department Debates
Legislation Debates
Peter Fortune has not made any spoken contributions to legislative debate
View all Peter Fortune's debates

Bromley and Biggin Hill Petitions

e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.

If an e-petition reaches 10,000 signatures the Government will issue a written response.

If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).

Peter Fortune has not participated in any petition debates

Latest EDMs signed by Peter Fortune

2nd September 2024
Peter Fortune signed this EDM on Monday 2nd September 2024

Social Security

Tabled by: Rishi Sunak (Conservative - Richmond and Northallerton)
That an humble Address be presented to His Majesty, praying that the Social Fund Winter Fuel Payment Regulations 2024 (S.I., 2024, No. 869), dated 22 August 2024, a copy of which was laid before this House on 22 August 2024, be annulled.
81 signatures
(Most recent: 10 Sep 2024)
Signatures by party:
Conservative: 75
Independent: 3
Democratic Unionist Party: 2
Scottish National Party: 1
View All Peter Fortune's signed Early Day Motions

Commons initiatives

These initiatives were driven by Peter Fortune, and are more likely to reflect personal policy preferences.

MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.


Peter Fortune has not been granted any Urgent Questions

Peter Fortune has not been granted any Adjournment Debates

Peter Fortune has not introduced any legislation before Parliament

Peter Fortune has not co-sponsored any Bills in the current parliamentary sitting


Latest 50 Written Questions

(View all written questions)
Written Questions can be tabled by MPs and Lords to request specific information information on the work, policy and activities of a Government Department
23rd Jan 2025
To ask the Secretary of State for Business and Trade, if he will make an assessment of the adequacy of the accessibility of the Competition and Markets Authority's SMS investigation into Google's general search and search advertising services, published on 14 January 2025.

The CMA has been given bespoke tools to increase competition in digital markets through the Digital Markets, Competition, Consumers Act 2024. Strategic Market Status investigations are the gateway into the regime and interested stakeholders can engage with the process, including firms under investigation, relevant third parties and the wider public.

Decisions on which SMS investigations to start are for the CMA as the UK’s independent competition authority.

Justin Madders
Parliamentary Under Secretary of State (Department for Business and Trade)
3rd Jan 2025
To ask the Secretary of State for Business and Trade, if he will make an assessment of the adequacy of the accessibility of the consultation entitled Investigation into suspected anti-competitive conduct by Vifor Pharma in relation to intravenous iron treatments, published on 31 January 2024.

The Competition and Markets Authority (CMA) is the UK's independent competition authority, and its consultations, including the live consultation relating to commitments offered by Vifor Pharma (https://www.gov.uk/government/consultations/consultation-on-proposed-commitments-in-respect-of-vifor-pharmas-supply-of-intravenous-iron), are therefore independent of Government. Any questions relating to consultations carried out by the CMA should be sent directly to the CMA.

Justin Madders
Parliamentary Under Secretary of State (Department for Business and Trade)
28th Nov 2024
To ask the Secretary of State for Business and Trade, if he will make an assessment of the adequacy of the accessibility of the consultation on the implementation of the new subscription contracts regime, published on 18 November 2024.

The consultation on the implementation of the subscription contracts follows the UK Government Consultation principles (Consultation principles: guidance - GOV.UK).

The subscription consultation is available in HTML and PDF formats. HTML provides greater accessibility for users. The PDF was published as an accessible PDF.

Alternative methods of completing the consultation are available including online, via email and via post.

Justin Madders
Parliamentary Under Secretary of State (Department for Business and Trade)
23rd Jan 2025
To ask the Secretary of State for Energy Security and Net Zero, if he will make an assessment of the adequacy of the accessibility of the consultation on Developing an energy smart data scheme, published on 13 January 2025.

The Department launched the call for evidence ‘Developing an energy smart data scheme’ on 13 January 2025, with more information available at the following link:

https://www.gov.uk/government/calls-for-evidence/developing-an-energy-smart-data-scheme (opens in a new tab)

As per the Department's accessible documents policy, the call for evidence document is published on GOV.UK and provided as both a tagged PDF and HTML so screen readers can understand the page structure. The digital survey for users to respond to the call for evidence is also hosted on an accessible platform.

Users of assistive technology (such as screen readers) can request a copy of the call for evidence in an accessible format by emailing alt.formats@energysecurity.gov.uk. Users who have queries on the call for evidence can also contact digitalisation@energysecurity.gov.uk.

Michael Shanks
Parliamentary Under Secretary of State (Department for Energy Security and Net Zero)
23rd Jan 2025
To ask the Secretary of State for Energy Security and Net Zero, if he will make an assessment of the adequacy of the accessibility of the consultation on Funding mechanism for the Hydrogen Production Business Model: proposed design of the Gas Shipper Obligation, published on 16 January 2025.

The Department launched the consultation ‘Funding mechanism for the Hydrogen Production Business Model: proposed design of the Gas Shipper Obligation’ on 16 January 2025, with more information available at the following link:

https://www.gov.uk/government/consultations/funding-mechanism-for-the-hydrogen-production-business-model-proposed-design-of-the-gas-shipper-obligation
(opens in a new tab)

As per the Department's accessible documents policy guidance, the consultation document is published on GOV.UK and provided as both a tagged PDF and HTML so screen readers can understand the page structure. The digital survey for users to respond to the consultation is also hosted on an accessible platform.

Users of assistive technology (such as screen readers) can request a copy of the consultation in an accessible format by emailing alt.formats@energysecurity.gov.uk. Users who have queries on the consultation can also contact GasShipperObligation@energysecurity.gov.uk.

Sarah Jones
Minister of State (Department for Energy Security and Net Zero)
10th Jan 2025
To ask the Secretary of State for Energy Security and Net Zero, if he will make an assessment with the Secretary of State for Science, Innovation and Technology of the adequacy of the accessibility of the consultation on UK Emissions Trading Scheme: free allocation review - carbon leakage, published on 16 December 2024.

The UK ETS Authority published the Free Allocation Review Carbon Leakage consultation in response to a call from stakeholders to see a draft UK Carbon Leakage List. The consultation also seeks to provides greater clarity on Free Allocation adjustments for sectors covered by the UK Carbon Border Adjustment Mechanism. While the consultation is technical in nature, there are annexes published alongside it to explain the methodology taken to develop proposals. In addition, during the consultation window over January to March, events for UK ETS participants and other interested stakeholders will take place to improve accessibility of the technical content.

Sarah Jones
Minister of State (Department for Energy Security and Net Zero)
10th Jan 2025
To ask the Secretary of State for Energy Security and Net Zero, if he will make an assessment of the adequacy of the accessibility of the consultation on Raising product standards for space heating, published on 17 December 2024.

The Department launched the consultation ‘Raising product standards for space heating’ on GOV.UK on 17 December 2024, with more information available at the following link:

https://www.gov.uk/government/consultations/raising-product-standards-for-space-heating (opens in a new tab)

Users of assistive technology (such as screen readers) can request a copy of the consultation and supporting documents in an accessible format by emailing alt.formats@energysecurity.gov.uk. Users who have queries on the consultation can also contact spaceheatingstandards@energysecurity.gov.uk.

Miatta Fahnbulleh
Parliamentary Under Secretary of State (Department for Energy Security and Net Zero)
10th Jan 2025
To ask the Secretary of State for Energy Security and Net Zero, if he will make an assessment of the adequacy of the accessibility of the consultation on Capacity Market: proposals to modernise Rules and improve participation and delivery assurance of consumer-led flexibility, published on 16 December 2024.

The Department published the consultation on Capacity Market: proposals to modernise Rules and improve participation and delivery assurance of consumer-led flexibility on GOV.UK and is content that it meets the expected accessibility standards to allow all interested parties to contribute their views.

Users of assistive technology (such as screen readers) can request a copy of the consultation in an alternative format by emailing alt.formats@energysecurity.gov.uk.

Michael Shanks
Parliamentary Under Secretary of State (Department for Energy Security and Net Zero)
28th Nov 2024
To ask the Secretary of State for Energy Security and Net Zero, if he will make an assessment of the adequacy of the accessibility of the consultation entitled Energy Company Obligation 4 and the Great British Insulation Scheme: mid-scheme changes, published on 14 November 2024.

Accessible versions of the Energy Company Obligation (ECO4) and Great British Insulation Scheme (GBIS) mid-scheme changes consultation (and all related documents) can be made available upon request at: https://www.gov.uk/government/consultations/energy-company-obligation-4-and-the-great-british-insulation-scheme-mid-scheme-changes

Requestors are asked to submit a form to the relevant team to ensure accessibility requests are reasonable and proportionate.

Miatta Fahnbulleh
Parliamentary Under Secretary of State (Department for Energy Security and Net Zero)
10th Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, what the total amount of Government investment into cholesteatoma research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care (DHSC) invests £1.5 billion per year on health research through the National Institute for Health and Care Research (NIHR). We are committed to funding timely research that leads to improved outcomes for patients and the public and makes the health and social care system more efficient, effective and safe. Research evidence is vital for improving treatments and outcomes for people, including those who experience hearing problems and tinnitus

Over the past five financial years (2019/20 – 2023/24), the NIHR has invested £3.3 million across 14 studies on these research topics directly through NIHR research programmes, with a further £1.1 million invested in career development and capacity for new hearing loss researchers. NIHR allocated £47,943 for research concerning otitis media and otitis media with effusion research in the financial year 2023-24.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, and mechanistic aspects that are applicable to many ear conditions. UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally.

MRC funds Doctoral Training Partnerships, a range of postgraduate training, in 2017-2024, MRC awarded £106, 564 for injury in blast-induced hearing loss and tinnitus research. In 2022 MRC also committed £1,014,670 for age-related hearing loss research, this project is active until 2025.

MRC Cognition and Brain Sciences Unit in Cambridge, supports two programmes of work that investigate the neural and cognitive mechanisms of hearing and speech (https://gtr.ukri.org/projects?ref=MC_UU_00030%2F4 and https://gtr.ukri.org/projects?ref=MC_UU_00030%2F6), as well as providing funding in 2023/24 for research into the different types of hearing loss https://gtr.ukri.org/projects?ref=MR%2FX019217%2F1.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
10th Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, what the total amount of Government investment into neurofibromatosis research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care (DHSC) invests £1.5 billion per year on health research through the National Institute for Health and Care Research (NIHR). We are committed to funding timely research that leads to improved outcomes for patients and the public and makes the health and social care system more efficient, effective and safe. Research evidence is vital for improving treatments and outcomes for people, including those who experience hearing problems and tinnitus

Over the past five financial years (2019/20 – 2023/24), the NIHR has invested £3.3 million across 14 studies on these research topics directly through NIHR research programmes, with a further £1.1 million invested in career development and capacity for new hearing loss researchers. NIHR allocated £47,943 for research concerning otitis media and otitis media with effusion research in the financial year 2023-24.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, and mechanistic aspects that are applicable to many ear conditions. UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally.

MRC funds Doctoral Training Partnerships, a range of postgraduate training, in 2017-2024, MRC awarded £106, 564 for injury in blast-induced hearing loss and tinnitus research. In 2022 MRC also committed £1,014,670 for age-related hearing loss research, this project is active until 2025.

MRC Cognition and Brain Sciences Unit in Cambridge, supports two programmes of work that investigate the neural and cognitive mechanisms of hearing and speech (https://gtr.ukri.org/projects?ref=MC_UU_00030%2F4 and https://gtr.ukri.org/projects?ref=MC_UU_00030%2F6), as well as providing funding in 2023/24 for research into the different types of hearing loss https://gtr.ukri.org/projects?ref=MR%2FX019217%2F1.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
10th Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, what the total amount of Government investment into noise induced hearing loss research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care (DHSC) invests £1.5 billion per year on health research through the National Institute for Health and Care Research (NIHR). We are committed to funding timely research that leads to improved outcomes for patients and the public and makes the health and social care system more efficient, effective and safe. Research evidence is vital for improving treatments and outcomes for people, including those who experience hearing problems and tinnitus

Over the past five financial years (2019/20 – 2023/24), the NIHR has invested £3.3 million across 14 studies on these research topics directly through NIHR research programmes, with a further £1.1 million invested in career development and capacity for new hearing loss researchers. NIHR allocated £47,943 for research concerning otitis media and otitis media with effusion research in the financial year 2023-24.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, and mechanistic aspects that are applicable to many ear conditions. UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally.

MRC funds Doctoral Training Partnerships, a range of postgraduate training, in 2017-2024, MRC awarded £106, 564 for injury in blast-induced hearing loss and tinnitus research. In 2022 MRC also committed £1,014,670 for age-related hearing loss research, this project is active until 2025.

MRC Cognition and Brain Sciences Unit in Cambridge, supports two programmes of work that investigate the neural and cognitive mechanisms of hearing and speech (https://gtr.ukri.org/projects?ref=MC_UU_00030%2F4 and https://gtr.ukri.org/projects?ref=MC_UU_00030%2F6), as well as providing funding in 2023/24 for research into the different types of hearing loss https://gtr.ukri.org/projects?ref=MR%2FX019217%2F1.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
10th Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, what the total amount of Government investment into age related hearing loss research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care (DHSC) invests £1.5 billion per year on health research through the National Institute for Health and Care Research (NIHR). We are committed to funding timely research that leads to improved outcomes for patients and the public and makes the health and social care system more efficient, effective and safe. Research evidence is vital for improving treatments and outcomes for people, including those who experience hearing problems and tinnitus

Over the past five financial years (2019/20 – 2023/24), the NIHR has invested £3.3 million across 14 studies on these research topics directly through NIHR research programmes, with a further £1.1 million invested in career development and capacity for new hearing loss researchers. NIHR allocated £47,943 for research concerning otitis media and otitis media with effusion research in the financial year 2023-24.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, and mechanistic aspects that are applicable to many ear conditions. UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally.

MRC funds Doctoral Training Partnerships, a range of postgraduate training, in 2017-2024, MRC awarded £106, 564 for injury in blast-induced hearing loss and tinnitus research. In 2022 MRC also committed £1,014,670 for age-related hearing loss research, this project is active until 2025.

MRC Cognition and Brain Sciences Unit in Cambridge, supports two programmes of work that investigate the neural and cognitive mechanisms of hearing and speech (https://gtr.ukri.org/projects?ref=MC_UU_00030%2F4 and https://gtr.ukri.org/projects?ref=MC_UU_00030%2F6), as well as providing funding in 2023/24 for research into the different types of hearing loss https://gtr.ukri.org/projects?ref=MR%2FX019217%2F1.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
10th Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, what the total amount of Government investment into congenital deafness research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care (DHSC) invests £1.5 billion per year on health research through the National Institute for Health and Care Research (NIHR). We are committed to funding timely research that leads to improved outcomes for patients and the public and makes the health and social care system more efficient, effective and safe. Research evidence is vital for improving treatments and outcomes for people, including those who experience hearing problems and tinnitus

Over the past five financial years (2019/20 – 2023/24), the NIHR has invested £3.3 million across 14 studies on these research topics directly through NIHR research programmes, with a further £1.1 million invested in career development and capacity for new hearing loss researchers. NIHR allocated £47,943 for research concerning otitis media and otitis media with effusion research in the financial year 2023-24.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, and mechanistic aspects that are applicable to many ear conditions. UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally.

MRC funds Doctoral Training Partnerships, a range of postgraduate training, in 2017-2024, MRC awarded £106, 564 for injury in blast-induced hearing loss and tinnitus research. In 2022 MRC also committed £1,014,670 for age-related hearing loss research, this project is active until 2025.

MRC Cognition and Brain Sciences Unit in Cambridge, supports two programmes of work that investigate the neural and cognitive mechanisms of hearing and speech (https://gtr.ukri.org/projects?ref=MC_UU_00030%2F4 and https://gtr.ukri.org/projects?ref=MC_UU_00030%2F6), as well as providing funding in 2023/24 for research into the different types of hearing loss https://gtr.ukri.org/projects?ref=MR%2FX019217%2F1.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
10th Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, what the total amount of Government investment into otosclerosis research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care (DHSC) invests £1.5 billion per year on health research through the National Institute for Health and Care Research (NIHR). We are committed to funding timely research that leads to improved outcomes for patients and the public and makes the health and social care system more efficient, effective and safe. Research evidence is vital for improving treatments and outcomes for people, including those who experience hearing problems and tinnitus

Over the past five financial years (2019/20 – 2023/24), the NIHR has invested £3.3 million across 14 studies on these research topics directly through NIHR research programmes, with a further £1.1 million invested in career development and capacity for new hearing loss researchers. NIHR allocated £47,943 for research concerning otitis media and otitis media with effusion research in the financial year 2023-24.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, and mechanistic aspects that are applicable to many ear conditions. UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally.

MRC funds Doctoral Training Partnerships, a range of postgraduate training, in 2017-2024, MRC awarded £106, 564 for injury in blast-induced hearing loss and tinnitus research. In 2022 MRC also committed £1,014,670 for age-related hearing loss research, this project is active until 2025.

MRC Cognition and Brain Sciences Unit in Cambridge, supports two programmes of work that investigate the neural and cognitive mechanisms of hearing and speech (https://gtr.ukri.org/projects?ref=MC_UU_00030%2F4 and https://gtr.ukri.org/projects?ref=MC_UU_00030%2F6), as well as providing funding in 2023/24 for research into the different types of hearing loss https://gtr.ukri.org/projects?ref=MR%2FX019217%2F1.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
10th Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, what the total amount of Government investment into tinnitus research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care (DHSC) invests £1.5 billion per year on health research through the National Institute for Health and Care Research (NIHR). We are committed to funding timely research that leads to improved outcomes for patients and the public and makes the health and social care system more efficient, effective and safe. Research evidence is vital for improving treatments and outcomes for people, including those who experience hearing problems and tinnitus

Over the past five financial years (2019/20 – 2023/24), the NIHR has invested £3.3 million across 14 studies on these research topics directly through NIHR research programmes, with a further £1.1 million invested in career development and capacity for new hearing loss researchers. NIHR allocated £47,943 for research concerning otitis media and otitis media with effusion research in the financial year 2023-24.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, and mechanistic aspects that are applicable to many ear conditions. UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally.

MRC funds Doctoral Training Partnerships, a range of postgraduate training, in 2017-2024, MRC awarded £106, 564 for injury in blast-induced hearing loss and tinnitus research. In 2022 MRC also committed £1,014,670 for age-related hearing loss research, this project is active until 2025.

MRC Cognition and Brain Sciences Unit in Cambridge, supports two programmes of work that investigate the neural and cognitive mechanisms of hearing and speech (https://gtr.ukri.org/projects?ref=MC_UU_00030%2F4 and https://gtr.ukri.org/projects?ref=MC_UU_00030%2F6), as well as providing funding in 2023/24 for research into the different types of hearing loss https://gtr.ukri.org/projects?ref=MR%2FX019217%2F1.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
10th Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, what the total amount of Government investment into meniere’s disease research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care (DHSC) invests £1.5 billion per year on health research through the National Institute for Health and Care Research (NIHR). We are committed to funding timely research that leads to improved outcomes for patients and the public and makes the health and social care system more efficient, effective and safe. Research evidence is vital for improving treatments and outcomes for people, including those who experience hearing problems and tinnitus

Over the past five financial years (2019/20 – 2023/24), the NIHR has invested £3.3 million across 14 studies on these research topics directly through NIHR research programmes, with a further £1.1 million invested in career development and capacity for new hearing loss researchers. NIHR allocated £47,943 for research concerning otitis media and otitis media with effusion research in the financial year 2023-24.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, and mechanistic aspects that are applicable to many ear conditions. UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally.

MRC funds Doctoral Training Partnerships, a range of postgraduate training, in 2017-2024, MRC awarded £106, 564 for injury in blast-induced hearing loss and tinnitus research. In 2022 MRC also committed £1,014,670 for age-related hearing loss research, this project is active until 2025.

MRC Cognition and Brain Sciences Unit in Cambridge, supports two programmes of work that investigate the neural and cognitive mechanisms of hearing and speech (https://gtr.ukri.org/projects?ref=MC_UU_00030%2F4 and https://gtr.ukri.org/projects?ref=MC_UU_00030%2F6), as well as providing funding in 2023/24 for research into the different types of hearing loss https://gtr.ukri.org/projects?ref=MR%2FX019217%2F1.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
10th Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, what the total amount of Government investment into labyrithitis research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care (DHSC) invests £1.5 billion per year on health research through the National Institute for Health and Care Research (NIHR). We are committed to funding timely research that leads to improved outcomes for patients and the public and makes the health and social care system more efficient, effective and safe. Research evidence is vital for improving treatments and outcomes for people, including those who experience hearing problems and tinnitus

Over the past five financial years (2019/20 – 2023/24), the NIHR has invested £3.3 million across 14 studies on these research topics directly through NIHR research programmes, with a further £1.1 million invested in career development and capacity for new hearing loss researchers. NIHR allocated £47,943 for research concerning otitis media and otitis media with effusion research in the financial year 2023-24.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, and mechanistic aspects that are applicable to many ear conditions. UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally.

MRC funds Doctoral Training Partnerships, a range of postgraduate training, in 2017-2024, MRC awarded £106, 564 for injury in blast-induced hearing loss and tinnitus research. In 2022 MRC also committed £1,014,670 for age-related hearing loss research, this project is active until 2025.

MRC Cognition and Brain Sciences Unit in Cambridge, supports two programmes of work that investigate the neural and cognitive mechanisms of hearing and speech (https://gtr.ukri.org/projects?ref=MC_UU_00030%2F4 and https://gtr.ukri.org/projects?ref=MC_UU_00030%2F6), as well as providing funding in 2023/24 for research into the different types of hearing loss https://gtr.ukri.org/projects?ref=MR%2FX019217%2F1.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
10th Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, what the total amount of Government investment into otitis media with effusion research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care (DHSC) invests £1.5 billion per year on health research through the National Institute for Health and Care Research (NIHR). We are committed to funding timely research that leads to improved outcomes for patients and the public and makes the health and social care system more efficient, effective and safe. Research evidence is vital for improving treatments and outcomes for people, including those who experience hearing problems and tinnitus

Over the past five financial years (2019/20 – 2023/24), the NIHR has invested £3.3 million across 14 studies on these research topics directly through NIHR research programmes, with a further £1.1 million invested in career development and capacity for new hearing loss researchers. NIHR allocated £47,943 for research concerning otitis media and otitis media with effusion research in the financial year 2023-24.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, and mechanistic aspects that are applicable to many ear conditions. UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally.

MRC funds Doctoral Training Partnerships, a range of postgraduate training, in 2017-2024, MRC awarded £106, 564 for injury in blast-induced hearing loss and tinnitus research. In 2022 MRC also committed £1,014,670 for age-related hearing loss research, this project is active until 2025.

MRC Cognition and Brain Sciences Unit in Cambridge, supports two programmes of work that investigate the neural and cognitive mechanisms of hearing and speech (https://gtr.ukri.org/projects?ref=MC_UU_00030%2F4 and https://gtr.ukri.org/projects?ref=MC_UU_00030%2F6), as well as providing funding in 2023/24 for research into the different types of hearing loss https://gtr.ukri.org/projects?ref=MR%2FX019217%2F1.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
10th Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, what the total amount of Government investment into otitis media research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care (DHSC) invests £1.5 billion per year on health research through the National Institute for Health and Care Research (NIHR). We are committed to funding timely research that leads to improved outcomes for patients and the public and makes the health and social care system more efficient, effective and safe. Research evidence is vital for improving treatments and outcomes for people, including those who experience hearing problems and tinnitus

Over the past five financial years (2019/20 – 2023/24), the NIHR has invested £3.3 million across 14 studies on these research topics directly through NIHR research programmes, with a further £1.1 million invested in career development and capacity for new hearing loss researchers. NIHR allocated £47,943 for research concerning otitis media and otitis media with effusion research in the financial year 2023-24.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, and mechanistic aspects that are applicable to many ear conditions. UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally.

MRC funds Doctoral Training Partnerships, a range of postgraduate training, in 2017-2024, MRC awarded £106, 564 for injury in blast-induced hearing loss and tinnitus research. In 2022 MRC also committed £1,014,670 for age-related hearing loss research, this project is active until 2025.

MRC Cognition and Brain Sciences Unit in Cambridge, supports two programmes of work that investigate the neural and cognitive mechanisms of hearing and speech (https://gtr.ukri.org/projects?ref=MC_UU_00030%2F4 and https://gtr.ukri.org/projects?ref=MC_UU_00030%2F6), as well as providing funding in 2023/24 for research into the different types of hearing loss https://gtr.ukri.org/projects?ref=MR%2FX019217%2F1.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
10th Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, what the total amount of Government investment into acoustic neuroma research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care (DHSC) invests £1.5 billion per year on health research through the National Institute for Health and Care Research (NIHR). We are committed to funding timely research that leads to improved outcomes for patients and the public and makes the health and social care system more efficient, effective and safe. Research evidence is vital for improving treatments and outcomes for people, including those who experience hearing problems and tinnitus

Over the past five financial years (2019/20 – 2023/24), the NIHR has invested £3.3 million across 14 studies on these research topics directly through NIHR research programmes, with a further £1.1 million invested in career development and capacity for new hearing loss researchers. NIHR allocated £47,943 for research concerning otitis media and otitis media with effusion research in the financial year 2023-24.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, and mechanistic aspects that are applicable to many ear conditions. UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally.

MRC funds Doctoral Training Partnerships, a range of postgraduate training, in 2017-2024, MRC awarded £106, 564 for injury in blast-induced hearing loss and tinnitus research. In 2022 MRC also committed £1,014,670 for age-related hearing loss research, this project is active until 2025.

MRC Cognition and Brain Sciences Unit in Cambridge, supports two programmes of work that investigate the neural and cognitive mechanisms of hearing and speech (https://gtr.ukri.org/projects?ref=MC_UU_00030%2F4 and https://gtr.ukri.org/projects?ref=MC_UU_00030%2F6), as well as providing funding in 2023/24 for research into the different types of hearing loss https://gtr.ukri.org/projects?ref=MR%2FX019217%2F1.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
3rd Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, how much funding the Government provided for research into alcoholic fatty liver disease in the 2023-24 financial year; and which public bodies provided that funding.

The Department of Health and Social Care (DHSC) funds medical research through the National Institute for Health and Care Research (NIHR). NIHR funds, enables, and delivers high-quality research to improve patient care and public health and supports liver research through a range of funding programmes, training, support for researchers and facilities.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, mechanistic and clinical studies to investigate the causes and underpin the development of treatments for a variety of liver conditions/diseases.

Details of UKRI and NIHR funding on specific areas is provided in the table below:

UIN

NIHR funding in FY 2023/24

UKRI Funding in FY 2023/24

28175

Hepatitis B

NIHR allocated £220,741 for research concerning Hepatitis B and Hepatitis C research in 2023-24.

The total commitment across UKRI in 2023-24 for Hepatitis B research was £1,810,412 for 2 awards from MRC.

28176

Hepatitis C

UKRI did not commit any specific funding for obstructive Hepatitis C research in 2023-24.

28177

Hepatocellular carcinoma

NIHR allocated £1,633,698 for research concerning hepatocellular carcinoma research in 2023-24.

The total commitment across UKRI in 2023-24 for hepatocellular carcinoma research was £2,758,044 for 5 awards (1 award from MRC and 4 awards from centrally managed UKRI schemes).

28178

Cholangiocarcinoma

NIHR did not allocate any funds concerning cholangiocarcinoma research in 2023-24

The total commitment across UKRI in 2023-24 for cholangiocarcinoma research was £187,096 (1 award from centrally managed UKRI schemes). The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) committed £17,595 in 2023-24 for cholangiocarcinoma research for 1 award.

28179

Biliary cirrhosis

NIHR did not allocate any funds concerning primary biliary cirrhosis research in 2023-24

UKRI did not commit any funding for primary biliary cirrhosis research in 2023-24.

28180

Sclerosing cholangitis

NIHR did not allocate any funds concerning primary sclerosing cholangitis research in 2023-24

UKRI did not commit any funding for primary sclerosing cholangitis research in 2023-24.

28181

Autoimmune hepatitis

NIHR did not allocate any funds concerning autoimmune hepatitis research in 2023-24

UKRI did not commit any funding for autoimmune hepatitis research in 2023-24.

28182

Non-alcoholic fatty liver disease

NIHR allocated £151,511 for research concerning non-alcoholic and alcoholic fatty liver disease research in 2023-24.

The total commitment across UKRI in 2023-24 for non-alcoholic fatty liver disease research was £3,647,138 for 4 awards (1 award from Innovate UK; 2 awards from MRC, 1 award from centrally managed UKRI schemes).

28183

Alcoholic fatty liver disease

UKRI did not commit any funding for alcoholic fatty liver disease research in 2023-24.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
3rd Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, how much funding the Government provided for research into non-alcoholic fatty liver disease in the 2023-24 financial year; and which public bodies provided that funding.

The Department of Health and Social Care (DHSC) funds medical research through the National Institute for Health and Care Research (NIHR). NIHR funds, enables, and delivers high-quality research to improve patient care and public health and supports liver research through a range of funding programmes, training, support for researchers and facilities.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, mechanistic and clinical studies to investigate the causes and underpin the development of treatments for a variety of liver conditions/diseases.

Details of UKRI and NIHR funding on specific areas is provided in the table below:

UIN

NIHR funding in FY 2023/24

UKRI Funding in FY 2023/24

28175

Hepatitis B

NIHR allocated £220,741 for research concerning Hepatitis B and Hepatitis C research in 2023-24.

The total commitment across UKRI in 2023-24 for Hepatitis B research was £1,810,412 for 2 awards from MRC.

28176

Hepatitis C

UKRI did not commit any specific funding for obstructive Hepatitis C research in 2023-24.

28177

Hepatocellular carcinoma

NIHR allocated £1,633,698 for research concerning hepatocellular carcinoma research in 2023-24.

The total commitment across UKRI in 2023-24 for hepatocellular carcinoma research was £2,758,044 for 5 awards (1 award from MRC and 4 awards from centrally managed UKRI schemes).

28178

Cholangiocarcinoma

NIHR did not allocate any funds concerning cholangiocarcinoma research in 2023-24

The total commitment across UKRI in 2023-24 for cholangiocarcinoma research was £187,096 (1 award from centrally managed UKRI schemes). The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) committed £17,595 in 2023-24 for cholangiocarcinoma research for 1 award.

28179

Biliary cirrhosis

NIHR did not allocate any funds concerning primary biliary cirrhosis research in 2023-24

UKRI did not commit any funding for primary biliary cirrhosis research in 2023-24.

28180

Sclerosing cholangitis

NIHR did not allocate any funds concerning primary sclerosing cholangitis research in 2023-24

UKRI did not commit any funding for primary sclerosing cholangitis research in 2023-24.

28181

Autoimmune hepatitis

NIHR did not allocate any funds concerning autoimmune hepatitis research in 2023-24

UKRI did not commit any funding for autoimmune hepatitis research in 2023-24.

28182

Non-alcoholic fatty liver disease

NIHR allocated £151,511 for research concerning non-alcoholic and alcoholic fatty liver disease research in 2023-24.

The total commitment across UKRI in 2023-24 for non-alcoholic fatty liver disease research was £3,647,138 for 4 awards (1 award from Innovate UK; 2 awards from MRC, 1 award from centrally managed UKRI schemes).

28183

Alcoholic fatty liver disease

UKRI did not commit any funding for alcoholic fatty liver disease research in 2023-24.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
3rd Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, how much funding the Government provided for research into autoimmune hepatitis in the 2023-24 financial year; and which public bodies provided that funding.

The Department of Health and Social Care (DHSC) funds medical research through the National Institute for Health and Care Research (NIHR). NIHR funds, enables, and delivers high-quality research to improve patient care and public health and supports liver research through a range of funding programmes, training, support for researchers and facilities.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, mechanistic and clinical studies to investigate the causes and underpin the development of treatments for a variety of liver conditions/diseases.

Details of UKRI and NIHR funding on specific areas is provided in the table below:

UIN

NIHR funding in FY 2023/24

UKRI Funding in FY 2023/24

28175

Hepatitis B

NIHR allocated £220,741 for research concerning Hepatitis B and Hepatitis C research in 2023-24.

The total commitment across UKRI in 2023-24 for Hepatitis B research was £1,810,412 for 2 awards from MRC.

28176

Hepatitis C

UKRI did not commit any specific funding for obstructive Hepatitis C research in 2023-24.

28177

Hepatocellular carcinoma

NIHR allocated £1,633,698 for research concerning hepatocellular carcinoma research in 2023-24.

The total commitment across UKRI in 2023-24 for hepatocellular carcinoma research was £2,758,044 for 5 awards (1 award from MRC and 4 awards from centrally managed UKRI schemes).

28178

Cholangiocarcinoma

NIHR did not allocate any funds concerning cholangiocarcinoma research in 2023-24

The total commitment across UKRI in 2023-24 for cholangiocarcinoma research was £187,096 (1 award from centrally managed UKRI schemes). The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) committed £17,595 in 2023-24 for cholangiocarcinoma research for 1 award.

28179

Biliary cirrhosis

NIHR did not allocate any funds concerning primary biliary cirrhosis research in 2023-24

UKRI did not commit any funding for primary biliary cirrhosis research in 2023-24.

28180

Sclerosing cholangitis

NIHR did not allocate any funds concerning primary sclerosing cholangitis research in 2023-24

UKRI did not commit any funding for primary sclerosing cholangitis research in 2023-24.

28181

Autoimmune hepatitis

NIHR did not allocate any funds concerning autoimmune hepatitis research in 2023-24

UKRI did not commit any funding for autoimmune hepatitis research in 2023-24.

28182

Non-alcoholic fatty liver disease

NIHR allocated £151,511 for research concerning non-alcoholic and alcoholic fatty liver disease research in 2023-24.

The total commitment across UKRI in 2023-24 for non-alcoholic fatty liver disease research was £3,647,138 for 4 awards (1 award from Innovate UK; 2 awards from MRC, 1 award from centrally managed UKRI schemes).

28183

Alcoholic fatty liver disease

UKRI did not commit any funding for alcoholic fatty liver disease research in 2023-24.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
3rd Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, how much funding the Government provided for research into primary sclerosing cholangitis in the 2023-24 financial year; and which public bodies provided that funding.

The Department of Health and Social Care (DHSC) funds medical research through the National Institute for Health and Care Research (NIHR). NIHR funds, enables, and delivers high-quality research to improve patient care and public health and supports liver research through a range of funding programmes, training, support for researchers and facilities.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, mechanistic and clinical studies to investigate the causes and underpin the development of treatments for a variety of liver conditions/diseases.

Details of UKRI and NIHR funding on specific areas is provided in the table below:

UIN

NIHR funding in FY 2023/24

UKRI Funding in FY 2023/24

28175

Hepatitis B

NIHR allocated £220,741 for research concerning Hepatitis B and Hepatitis C research in 2023-24.

The total commitment across UKRI in 2023-24 for Hepatitis B research was £1,810,412 for 2 awards from MRC.

28176

Hepatitis C

UKRI did not commit any specific funding for obstructive Hepatitis C research in 2023-24.

28177

Hepatocellular carcinoma

NIHR allocated £1,633,698 for research concerning hepatocellular carcinoma research in 2023-24.

The total commitment across UKRI in 2023-24 for hepatocellular carcinoma research was £2,758,044 for 5 awards (1 award from MRC and 4 awards from centrally managed UKRI schemes).

28178

Cholangiocarcinoma

NIHR did not allocate any funds concerning cholangiocarcinoma research in 2023-24

The total commitment across UKRI in 2023-24 for cholangiocarcinoma research was £187,096 (1 award from centrally managed UKRI schemes). The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) committed £17,595 in 2023-24 for cholangiocarcinoma research for 1 award.

28179

Biliary cirrhosis

NIHR did not allocate any funds concerning primary biliary cirrhosis research in 2023-24

UKRI did not commit any funding for primary biliary cirrhosis research in 2023-24.

28180

Sclerosing cholangitis

NIHR did not allocate any funds concerning primary sclerosing cholangitis research in 2023-24

UKRI did not commit any funding for primary sclerosing cholangitis research in 2023-24.

28181

Autoimmune hepatitis

NIHR did not allocate any funds concerning autoimmune hepatitis research in 2023-24

UKRI did not commit any funding for autoimmune hepatitis research in 2023-24.

28182

Non-alcoholic fatty liver disease

NIHR allocated £151,511 for research concerning non-alcoholic and alcoholic fatty liver disease research in 2023-24.

The total commitment across UKRI in 2023-24 for non-alcoholic fatty liver disease research was £3,647,138 for 4 awards (1 award from Innovate UK; 2 awards from MRC, 1 award from centrally managed UKRI schemes).

28183

Alcoholic fatty liver disease

UKRI did not commit any funding for alcoholic fatty liver disease research in 2023-24.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
3rd Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, how much funding the Government provided for research into primary biliary cirrhosis in the 2023-24 financial year; and which public bodies provided that funding.

The Department of Health and Social Care (DHSC) funds medical research through the National Institute for Health and Care Research (NIHR). NIHR funds, enables, and delivers high-quality research to improve patient care and public health and supports liver research through a range of funding programmes, training, support for researchers and facilities.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, mechanistic and clinical studies to investigate the causes and underpin the development of treatments for a variety of liver conditions/diseases.

Details of UKRI and NIHR funding on specific areas is provided in the table below:

UIN

NIHR funding in FY 2023/24

UKRI Funding in FY 2023/24

28175

Hepatitis B

NIHR allocated £220,741 for research concerning Hepatitis B and Hepatitis C research in 2023-24.

The total commitment across UKRI in 2023-24 for Hepatitis B research was £1,810,412 for 2 awards from MRC.

28176

Hepatitis C

UKRI did not commit any specific funding for obstructive Hepatitis C research in 2023-24.

28177

Hepatocellular carcinoma

NIHR allocated £1,633,698 for research concerning hepatocellular carcinoma research in 2023-24.

The total commitment across UKRI in 2023-24 for hepatocellular carcinoma research was £2,758,044 for 5 awards (1 award from MRC and 4 awards from centrally managed UKRI schemes).

28178

Cholangiocarcinoma

NIHR did not allocate any funds concerning cholangiocarcinoma research in 2023-24

The total commitment across UKRI in 2023-24 for cholangiocarcinoma research was £187,096 (1 award from centrally managed UKRI schemes). The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) committed £17,595 in 2023-24 for cholangiocarcinoma research for 1 award.

28179

Biliary cirrhosis

NIHR did not allocate any funds concerning primary biliary cirrhosis research in 2023-24

UKRI did not commit any funding for primary biliary cirrhosis research in 2023-24.

28180

Sclerosing cholangitis

NIHR did not allocate any funds concerning primary sclerosing cholangitis research in 2023-24

UKRI did not commit any funding for primary sclerosing cholangitis research in 2023-24.

28181

Autoimmune hepatitis

NIHR did not allocate any funds concerning autoimmune hepatitis research in 2023-24

UKRI did not commit any funding for autoimmune hepatitis research in 2023-24.

28182

Non-alcoholic fatty liver disease

NIHR allocated £151,511 for research concerning non-alcoholic and alcoholic fatty liver disease research in 2023-24.

The total commitment across UKRI in 2023-24 for non-alcoholic fatty liver disease research was £3,647,138 for 4 awards (1 award from Innovate UK; 2 awards from MRC, 1 award from centrally managed UKRI schemes).

28183

Alcoholic fatty liver disease

UKRI did not commit any funding for alcoholic fatty liver disease research in 2023-24.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
3rd Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, how much funding the Government provided for research into cholangiocarcinoma in the 2023-24 financial year; and which public bodies provided that funding.

The Department of Health and Social Care (DHSC) funds medical research through the National Institute for Health and Care Research (NIHR). NIHR funds, enables, and delivers high-quality research to improve patient care and public health and supports liver research through a range of funding programmes, training, support for researchers and facilities.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, mechanistic and clinical studies to investigate the causes and underpin the development of treatments for a variety of liver conditions/diseases.

Details of UKRI and NIHR funding on specific areas is provided in the table below:

UIN

NIHR funding in FY 2023/24

UKRI Funding in FY 2023/24

28175

Hepatitis B

NIHR allocated £220,741 for research concerning Hepatitis B and Hepatitis C research in 2023-24.

The total commitment across UKRI in 2023-24 for Hepatitis B research was £1,810,412 for 2 awards from MRC.

28176

Hepatitis C

UKRI did not commit any specific funding for obstructive Hepatitis C research in 2023-24.

28177

Hepatocellular carcinoma

NIHR allocated £1,633,698 for research concerning hepatocellular carcinoma research in 2023-24.

The total commitment across UKRI in 2023-24 for hepatocellular carcinoma research was £2,758,044 for 5 awards (1 award from MRC and 4 awards from centrally managed UKRI schemes).

28178

Cholangiocarcinoma

NIHR did not allocate any funds concerning cholangiocarcinoma research in 2023-24

The total commitment across UKRI in 2023-24 for cholangiocarcinoma research was £187,096 (1 award from centrally managed UKRI schemes). The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) committed £17,595 in 2023-24 for cholangiocarcinoma research for 1 award.

28179

Biliary cirrhosis

NIHR did not allocate any funds concerning primary biliary cirrhosis research in 2023-24

UKRI did not commit any funding for primary biliary cirrhosis research in 2023-24.

28180

Sclerosing cholangitis

NIHR did not allocate any funds concerning primary sclerosing cholangitis research in 2023-24

UKRI did not commit any funding for primary sclerosing cholangitis research in 2023-24.

28181

Autoimmune hepatitis

NIHR did not allocate any funds concerning autoimmune hepatitis research in 2023-24

UKRI did not commit any funding for autoimmune hepatitis research in 2023-24.

28182

Non-alcoholic fatty liver disease

NIHR allocated £151,511 for research concerning non-alcoholic and alcoholic fatty liver disease research in 2023-24.

The total commitment across UKRI in 2023-24 for non-alcoholic fatty liver disease research was £3,647,138 for 4 awards (1 award from Innovate UK; 2 awards from MRC, 1 award from centrally managed UKRI schemes).

28183

Alcoholic fatty liver disease

UKRI did not commit any funding for alcoholic fatty liver disease research in 2023-24.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
3rd Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, how much funding the Government provided for research into hepatocellular carcinoma in the 2023-24 financial year; and which public bodies provided that funding.

The Department of Health and Social Care (DHSC) funds medical research through the National Institute for Health and Care Research (NIHR). NIHR funds, enables, and delivers high-quality research to improve patient care and public health and supports liver research through a range of funding programmes, training, support for researchers and facilities.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, mechanistic and clinical studies to investigate the causes and underpin the development of treatments for a variety of liver conditions/diseases.

Details of UKRI and NIHR funding on specific areas is provided in the table below:

UIN

NIHR funding in FY 2023/24

UKRI Funding in FY 2023/24

28175

Hepatitis B

NIHR allocated £220,741 for research concerning Hepatitis B and Hepatitis C research in 2023-24.

The total commitment across UKRI in 2023-24 for Hepatitis B research was £1,810,412 for 2 awards from MRC.

28176

Hepatitis C

UKRI did not commit any specific funding for obstructive Hepatitis C research in 2023-24.

28177

Hepatocellular carcinoma

NIHR allocated £1,633,698 for research concerning hepatocellular carcinoma research in 2023-24.

The total commitment across UKRI in 2023-24 for hepatocellular carcinoma research was £2,758,044 for 5 awards (1 award from MRC and 4 awards from centrally managed UKRI schemes).

28178

Cholangiocarcinoma

NIHR did not allocate any funds concerning cholangiocarcinoma research in 2023-24

The total commitment across UKRI in 2023-24 for cholangiocarcinoma research was £187,096 (1 award from centrally managed UKRI schemes). The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) committed £17,595 in 2023-24 for cholangiocarcinoma research for 1 award.

28179

Biliary cirrhosis

NIHR did not allocate any funds concerning primary biliary cirrhosis research in 2023-24

UKRI did not commit any funding for primary biliary cirrhosis research in 2023-24.

28180

Sclerosing cholangitis

NIHR did not allocate any funds concerning primary sclerosing cholangitis research in 2023-24

UKRI did not commit any funding for primary sclerosing cholangitis research in 2023-24.

28181

Autoimmune hepatitis

NIHR did not allocate any funds concerning autoimmune hepatitis research in 2023-24

UKRI did not commit any funding for autoimmune hepatitis research in 2023-24.

28182

Non-alcoholic fatty liver disease

NIHR allocated £151,511 for research concerning non-alcoholic and alcoholic fatty liver disease research in 2023-24.

The total commitment across UKRI in 2023-24 for non-alcoholic fatty liver disease research was £3,647,138 for 4 awards (1 award from Innovate UK; 2 awards from MRC, 1 award from centrally managed UKRI schemes).

28183

Alcoholic fatty liver disease

UKRI did not commit any funding for alcoholic fatty liver disease research in 2023-24.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
3rd Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, how much funding the Government provided for research into Hepatitis C in the 2023-24 financial year; and which public bodies provided that funding.

The Department of Health and Social Care (DHSC) funds medical research through the National Institute for Health and Care Research (NIHR). NIHR funds, enables, and delivers high-quality research to improve patient care and public health and supports liver research through a range of funding programmes, training, support for researchers and facilities.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, mechanistic and clinical studies to investigate the causes and underpin the development of treatments for a variety of liver conditions/diseases.

Details of UKRI and NIHR funding on specific areas is provided in the table below:

UIN

NIHR funding in FY 2023/24

UKRI Funding in FY 2023/24

28175

Hepatitis B

NIHR allocated £220,741 for research concerning Hepatitis B and Hepatitis C research in 2023-24.

The total commitment across UKRI in 2023-24 for Hepatitis B research was £1,810,412 for 2 awards from MRC.

28176

Hepatitis C

UKRI did not commit any specific funding for obstructive Hepatitis C research in 2023-24.

28177

Hepatocellular carcinoma

NIHR allocated £1,633,698 for research concerning hepatocellular carcinoma research in 2023-24.

The total commitment across UKRI in 2023-24 for hepatocellular carcinoma research was £2,758,044 for 5 awards (1 award from MRC and 4 awards from centrally managed UKRI schemes).

28178

Cholangiocarcinoma

NIHR did not allocate any funds concerning cholangiocarcinoma research in 2023-24

The total commitment across UKRI in 2023-24 for cholangiocarcinoma research was £187,096 (1 award from centrally managed UKRI schemes). The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) committed £17,595 in 2023-24 for cholangiocarcinoma research for 1 award.

28179

Biliary cirrhosis

NIHR did not allocate any funds concerning primary biliary cirrhosis research in 2023-24

UKRI did not commit any funding for primary biliary cirrhosis research in 2023-24.

28180

Sclerosing cholangitis

NIHR did not allocate any funds concerning primary sclerosing cholangitis research in 2023-24

UKRI did not commit any funding for primary sclerosing cholangitis research in 2023-24.

28181

Autoimmune hepatitis

NIHR did not allocate any funds concerning autoimmune hepatitis research in 2023-24

UKRI did not commit any funding for autoimmune hepatitis research in 2023-24.

28182

Non-alcoholic fatty liver disease

NIHR allocated £151,511 for research concerning non-alcoholic and alcoholic fatty liver disease research in 2023-24.

The total commitment across UKRI in 2023-24 for non-alcoholic fatty liver disease research was £3,647,138 for 4 awards (1 award from Innovate UK; 2 awards from MRC, 1 award from centrally managed UKRI schemes).

28183

Alcoholic fatty liver disease

UKRI did not commit any funding for alcoholic fatty liver disease research in 2023-24.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
3rd Feb 2025
To ask the Secretary of State for Science, Innovation and Technology, how much funding the Government provided for research into Hepatitis B in the 2023-24 financial year; and which public bodies provided that funding.

The Department of Health and Social Care (DHSC) funds medical research through the National Institute for Health and Care Research (NIHR). NIHR funds, enables, and delivers high-quality research to improve patient care and public health and supports liver research through a range of funding programmes, training, support for researchers and facilities.

UKRI delivers a substantial portfolio of researcher-led projects. This includes biological, physiological, mechanistic and clinical studies to investigate the causes and underpin the development of treatments for a variety of liver conditions/diseases.

Details of UKRI and NIHR funding on specific areas is provided in the table below:

UIN

NIHR funding in FY 2023/24

UKRI Funding in FY 2023/24

28175

Hepatitis B

NIHR allocated £220,741 for research concerning Hepatitis B and Hepatitis C research in 2023-24.

The total commitment across UKRI in 2023-24 for Hepatitis B research was £1,810,412 for 2 awards from MRC.

28176

Hepatitis C

UKRI did not commit any specific funding for obstructive Hepatitis C research in 2023-24.

28177

Hepatocellular carcinoma

NIHR allocated £1,633,698 for research concerning hepatocellular carcinoma research in 2023-24.

The total commitment across UKRI in 2023-24 for hepatocellular carcinoma research was £2,758,044 for 5 awards (1 award from MRC and 4 awards from centrally managed UKRI schemes).

28178

Cholangiocarcinoma

NIHR did not allocate any funds concerning cholangiocarcinoma research in 2023-24

The total commitment across UKRI in 2023-24 for cholangiocarcinoma research was £187,096 (1 award from centrally managed UKRI schemes). The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) committed £17,595 in 2023-24 for cholangiocarcinoma research for 1 award.

28179

Biliary cirrhosis

NIHR did not allocate any funds concerning primary biliary cirrhosis research in 2023-24

UKRI did not commit any funding for primary biliary cirrhosis research in 2023-24.

28180

Sclerosing cholangitis

NIHR did not allocate any funds concerning primary sclerosing cholangitis research in 2023-24

UKRI did not commit any funding for primary sclerosing cholangitis research in 2023-24.

28181

Autoimmune hepatitis

NIHR did not allocate any funds concerning autoimmune hepatitis research in 2023-24

UKRI did not commit any funding for autoimmune hepatitis research in 2023-24.

28182

Non-alcoholic fatty liver disease

NIHR allocated £151,511 for research concerning non-alcoholic and alcoholic fatty liver disease research in 2023-24.

The total commitment across UKRI in 2023-24 for non-alcoholic fatty liver disease research was £3,647,138 for 4 awards (1 award from Innovate UK; 2 awards from MRC, 1 award from centrally managed UKRI schemes).

28183

Alcoholic fatty liver disease

UKRI did not commit any funding for alcoholic fatty liver disease research in 2023-24.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
23rd Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, whether he has had discussions with Innovate UK on their (a) cybersecurity and (b) procedures to prevent cyber and ransomware attacks since July 2024; and how many such incidents have occurred since July 2024.

Ministers and officials meet regularly with industry stakeholders and public bodies to discuss cyber security and bolstering cyber resilience. The National Cyber Security Centre offers range of support and guidance showing businesses, agencies and government departments how to protect against cyber attacks. The Cyber Breaches Survey 2024 shows that 50% of businesses report having experienced some form of cyber security breach or attack in the last 12 months. The Government recognises the importance of strengthening the UK’s cyber resilience and protecting the digital economy to deliver growth. To address this, the Government is introducing a Cyber Security and Resilience Bill. The Bill will strengthen the UK’s cyber defences and ensure that more essential digital services than ever before are protected. On 14 January the government published a consultation on proposals to further protect businesses and public services from ransomware attacks.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
23rd Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, whether he has had discussions with the Science and Technology Facilities Council on their (a) cybersecurity and (b) procedures to prevent cyber and ransomware attacks since July 2024; and how many such incidents have occurred since July 2024.

Ministers and officials meet regularly with industry stakeholders and public bodies to discuss cyber security and bolstering cyber resilience. The National Cyber Security Centre offers range of support and guidance showing businesses, agencies and government departments how to protect against cyber attacks. The Cyber Breaches Survey 2024 shows that 50% of businesses report having experienced some form of cyber security breach or attack in the last 12 months. The Government recognises the importance of strengthening the UK’s cyber resilience and protecting the digital economy to deliver growth. To address this, the Government is introducing a Cyber Security and Resilience Bill. The Bill will strengthen the UK’s cyber defences and ensure that more essential digital services than ever before are protected. On 14 January the government published a consultation on proposals to further protect businesses and public services from ransomware attacks.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
23rd Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, whether he has had discussions with the Geospatial Commission on their (a) cybersecurity and (b) procedures to prevent cyber and ransomware attacks since July 2024; and how many such incidents have occurred since July 2024.

Ministers and officials meet regularly with industry stakeholders and public bodies to discuss cyber security and bolstering cyber resilience. The National Cyber Security Centre offers range of support and guidance showing businesses, agencies and government departments how to protect against cyber attacks. The Cyber Breaches Survey 2024 shows that 50% of businesses report having experienced some form of cyber security breach or attack in the last 12 months. The Government recognises the importance of strengthening the UK’s cyber resilience and protecting the digital economy to deliver growth. To address this, the Government is introducing a Cyber Security and Resilience Bill. The Bill will strengthen the UK’s cyber defences and ensure that more essential digital services than ever before are protected. On 14 January the government published a consultation on proposals to further protect businesses and public services from ransomware attacks.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
23rd Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, whether he has had discussions with the Natural Environment Research Council on their (a) cybersecurity and (b) procedures to prevent cyber and ransomware attacks since July 2024; and how many such incidents have occurred since July 2024.

Ministers and officials meet regularly with industry stakeholders and public bodies to discuss cyber security and bolstering cyber resilience. The National Cyber Security Centre offers range of support and guidance showing businesses, agencies and government departments how to protect against cyber attacks. The Cyber Breaches Survey 2024 shows that 50% of businesses report having experienced some form of cyber security breach or attack in the last 12 months. The Government recognises the importance of strengthening the UK’s cyber resilience and protecting the digital economy to deliver growth. To address this, the Government is introducing a Cyber Security and Resilience Bill. The Bill will strengthen the UK’s cyber defences and ensure that more essential digital services than ever before are protected. On 14 January the government published a consultation on proposals to further protect businesses and public services from ransomware attacks.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
23rd Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, whether he has had discussions with the Engineering and Physical Sciences Research Council on their (a) cybersecurity and (b) procedures to prevent cyber and ransomware attacks since July 2024; and how many such incidents have occurred since July 2024.

Ministers and officials meet regularly with industry stakeholders and public bodies to discuss cyber security and bolstering cyber resilience. The National Cyber Security Centre offers range of support and guidance showing businesses, agencies and government departments how to protect against cyber attacks. The Cyber Breaches Survey 2024 shows that 50% of businesses report having experienced some form of cyber security breach or attack in the last 12 months. The Government recognises the importance of strengthening the UK’s cyber resilience and protecting the digital economy to deliver growth. To address this, the Government is introducing a Cyber Security and Resilience Bill. The Bill will strengthen the UK’s cyber defences and ensure that more essential digital services than ever before are protected. On 14 January the government published a consultation on proposals to further protect businesses and public services from ransomware attacks.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
23rd Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, whether he has had discussions with the Biotechnology and Biological Sciences Research Council on their (a) cybersecurity and (b) procedures to prevent cyber and ransomware attacks since July 2024; and how many such incidents have occurred since July 2024.

Ministers and officials meet regularly with industry stakeholders and public bodies to discuss cyber security and bolstering cyber resilience. The National Cyber Security Centre offers range of support and guidance showing businesses, agencies and government departments how to protect against cyber attacks. The Cyber Breaches Survey 2024 shows that 50% of businesses report having experienced some form of cyber security breach or attack in the last 12 months. The Government recognises the importance of strengthening the UK’s cyber resilience and protecting the digital economy to deliver growth. To address this, the Government is introducing a Cyber Security and Resilience Bill. The Bill will strengthen the UK’s cyber defences and ensure that more essential digital services than ever before are protected. On 14 January the government published a consultation on proposals to further protect businesses and public services from ransomware attacks.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
23rd Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, whether he has had discussions with the Economic and Social Research Council on their (a) cybersecurity and (b) procedures to prevent cyber and ransomware attacks since July 2024; and how many such incidents have occurred since July 2024.

Ministers and officials meet regularly with industry stakeholders and public bodies to discuss cyber security and bolstering cyber resilience. The National Cyber Security Centre offers range of support and guidance showing businesses, agencies and government departments how to protect against cyber attacks. The Cyber Breaches Survey 2024 shows that 50% of businesses report having experienced some form of cyber security breach or attack in the last 12 months. The Government recognises the importance of strengthening the UK’s cyber resilience and protecting the digital economy to deliver growth. To address this, the Government is introducing a Cyber Security and Resilience Bill. The Bill will strengthen the UK’s cyber defences and ensure that more essential digital services than ever before are protected. On 14 January the government published a consultation on proposals to further protect businesses and public services from ransomware attacks.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
23rd Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, whether he has had discussions with the Arts and Humanities Research Council on their (a) cybersecurity and (b) procedures to prevent cyber and ransomware attacks since July 2024; and how many such incidents have occurred since July 2024.

Ministers and officials meet regularly with industry stakeholders and public bodies to discuss cyber security and bolstering cyber resilience. The National Cyber Security Centre offers range of support and guidance showing businesses, agencies and government departments how to protect against cyber attacks. The Cyber Breaches Survey 2024 shows that 50% of businesses report having experienced some form of cyber security breach or attack in the last 12 months. The Government recognises the importance of strengthening the UK’s cyber resilience and protecting the digital economy to deliver growth. To address this, the Government is introducing a Cyber Security and Resilience Bill. The Bill will strengthen the UK’s cyber defences and ensure that more essential digital services than ever before are protected. On 14 January the government published a consultation on proposals to further protect businesses and public services from ransomware attacks.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
23rd Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, whether he has had discussions with the Advanced Research and Invention Agency on their (a) cybersecurity and (b) procedures to prevent cyber and ransomware attacks since July 2024; and how many such incidents have occurred since July 2024.

Ministers and officials meet regularly with industry stakeholders and public bodies to discuss cyber security and bolstering cyber resilience. The National Cyber Security Centre offers range of support and guidance showing businesses, agencies and government departments how to protect against cyber attacks. The Cyber Breaches Survey 2024 shows that 50% of businesses report having experienced some form of cyber security breach or attack in the last 12 months. The Government recognises the importance of strengthening the UK’s cyber resilience and protecting the digital economy to deliver growth. To address this, the Government is introducing a Cyber Security and Resilience Bill. The Bill will strengthen the UK’s cyber defences and ensure that more essential digital services than ever before are protected. On 14 January the government published a consultation on proposals to further protect businesses and public services from ransomware attacks.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
17th Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, what discussions he had with businesses on the AI Opportunities Action Plan before its publication.

The AI Opportunities Action Plan, which was developed by Matt Clifford, sets out how we will achieve our ambitions by laying the foundations for AI growth, driving adoption and building UK capability at the frontier.

The Action Plan has been informed by a series of external roundtables with experts from across the AI ecosystem. These discussions covered key areas such as the collaboration between the public and private sectors to create a robust AI ecosystem and to unmask the potential economic impact of AI technologies. As the Government takes the Plan forward, it will continue to engage widely with these stakeholders to ensure its implementation.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
17th Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, what discussions he had with Horizon Europe on the AI Opportunities Action Plan before its publication.

The AI Opportunities Action Plan, which was developed by Matt Clifford, sets out how we will achieve our AI ambitions by laying the foundations for AI growth, driving adoption and building UK capability at the frontier.

The Action Plan was informed by a series of external roundtables with experts from across the AI ecosystem including civil society, academia, investors, and industry, including from UKRI. The department also regularly engages with the Horizon Programme and the responsible EU officials. These discussions have informed the action plan and continue to shape our ongoing work.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
17th Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, what discussions he had with the Geospatial Commission on the AI Opportunities Action Plan before its publication.

The AI Opportunities Action Plan, which was developed by Matt Clifford, sets out how we will achieve our AI ambitions by laying the foundations for AI growth, driving adoption and building UK capability at the frontier.

The Secretary of State for Science, Innovation and Technology engaged in numerous discussions with various stakeholders and government departments as part of the broader effort to ensure the AI Opportunities Action Plan was comprehensive and aligned with the government’s ambition for growth. The Geospatial Commission is part of the Department for Science, Innovation and Technology. Officials in geospatial and AI policy engage regularly, including on the AI Action Plan.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
17th Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, what discussions he had with the UKRI on the AI Opportunities Action Plan before its publication.

The AI Opportunities Action Plan, which was developed by Matt Clifford, sets out how we will achieve our AI ambitions by laying the foundations for AI growth, driving adoption and building UK capability at the frontier.

UKRI representatives, including research councils, have been engaged throughout the development of the AI Opportunities Action Plan. We are committed to working closely with the UKRI who are a critical delivery partner for key elements of the Action plan. We will continue to engage widely across the AI ecosystem as government takes the Action Plan forward.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
17th Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, what discussions he had with Research England on the AI Opportunities Action Plan before its publication.

The AI Opportunities Action Plan, which was developed by Matt Clifford, sets out how we will achieve our AI ambitions by laying the foundations for AI growth, driving adoption and building UK capability at the frontier.

UKRI representatives, including research councils, have been engaged throughout the development of the AI Opportunities Action Plan. We are committed to working closely with the UKRI who are a critical delivery partner for key elements of the Action plan. We will continue to engage widely across the AI ecosystem as government takes the Action Plan forward.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
17th Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, what discussions he had with Innovate UK on the AI Opportunities Action Plan before its publication.

The AI Opportunities Action Plan, which was developed by Matt Clifford, sets out how we will achieve our AI ambitions by laying the foundations for AI growth, driving adoption and building UK capability at the frontier.

UKRI representatives, including research councils, have been engaged throughout the development of the AI Opportunities Action Plan. We are committed to working closely with the UKRI who are a critical delivery partner for key elements of the Action plan. We will continue to engage widely across the AI ecosystem as government takes the Action Plan forward.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
17th Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, what discussions he had with the Science and Technology Facilities Council on the AI Opportunities Action Plan before its publication.

The AI Opportunities Action Plan, which was developed by Matt Clifford, sets out how we will achieve our AI ambitions by laying the foundations for AI growth, driving adoption and building UK capability at the frontier.

UKRI representatives, including research councils, have been engaged throughout the development of the AI Opportunities Action Plan. We are committed to working closely with the UKRI who are a critical delivery partner for key elements of the Action plan. We will continue to engage widely across the AI ecosystem as government takes the Action Plan forward.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
17th Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, what discussions he had with the Natural Environment Research Council on the AI Opportunities Action Plan before its publication.

The AI Opportunities Action Plan, which was developed by Matt Clifford, sets out how we will achieve our AI ambitions by laying the foundations for AI growth, driving adoption and building UK capability at the frontier.

UKRI representatives, including research councils, have been engaged throughout the development of the AI Opportunities Action Plan. We are committed to working closely with the UKRI who are a critical delivery partner for key elements of the Action plan. We will continue to engage widely across the AI ecosystem as government takes the Action Plan forward.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
17th Jan 2025
To ask the Secretary of State for Science, Innovation and Technology, what discussions he had with the Medical Research Council on the AI Opportunities Action Plan before its publication.

The AI Opportunities Action Plan, which was developed by Matt Clifford, sets out how we will achieve our AI ambitions by laying the foundations for AI growth, driving adoption and building UK capability at the frontier.

UKRI representatives, including research councils, have been engaged throughout the development of the AI Opportunities Action Plan. We are committed to working closely with the UKRI who are a critical delivery partner for key elements of the Action plan. We will continue to engage widely across the AI ecosystem as government takes the Action Plan forward.

Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)